{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T16:10:19Z","timestamp":1746115819354,"version":"3.40.4"},"reference-count":16,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Clinical pharmacology as an interdisciplinary science is unique in its capacity and the diversity of the methods and approaches it can provide to derive dosing recommendations in various subpopulations. This article illustrates cases where an integrated clinical pharmacology approach was used to derive dosing recommendations for psychiatry drugs within regulatory settings. The integrated approach is based on the view that once a drug is shown to be effective in the general population, it is reasonable to take into consideration other relevant findings and the use of alternative scientific tools and analysis to derive dosing recommendations in specific populations. The method provides useful means to solve the challenges of the paucity of available data and lead to clear dosing instructions. This in turn expands the benefits of any given drug to all individuals in which the drug is likely to be effective.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcph.118","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T13:34:55Z","timestamp":1373463295000},"page":"1005-1009","source":"Crossref","is-referenced-by-count":0,"title":["An integrated clinical pharmacology approach for deriving dosing recommendations in a regulatory setting: Review of recent cases in psychiatry drugs"],"prefix":"10.1002","volume":"53","author":[{"given":"Islam R.","family":"Younis","sequence":"first","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hobart","family":"Rogers","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramana S.","family":"Uppoor","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehul U.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07572"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000166405.49473.70"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262110-00006"},{"issue":"2","key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)37449-X","article-title":"Identification and characterization of human cytochrome P450 isoforms interacting with pimozide","volume":"285","author":"Desta Z","year":"1998","journal-title":"J Pharmacol Exp Ther."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199409000-00022"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.11.1751b"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.5.673"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.07.013"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828393a8"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.06.021"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181ee84c7"},{"key":"e_1_2_8_13_1","unstructured":"Drug Approval Package. Latuda\u00ae (lurasidone hydrochloride) Application No. 200603.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/200603Orig1s000TOC.cfmDecember 28 2010. Last accessed November 02 2013."},{"key":"e_1_2_8_14_1","unstructured":"Drug Approval Letter. Latuda\u00ae (lurasidone hydrochloride) Application No. 200603\u2010S005.http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2012\/200603s005 s007ltr.pdfApril 26 2012. Last accessed February 11 2013."},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.01.009"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70038-X"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2003.08.013"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.118","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:04:55Z","timestamp":1746018295000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1002\/jcph.118"],"URL":"https:\/\/doi.org\/10.1002\/jcph.118","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"type":"print","value":"0091-2700"},{"type":"electronic","value":"1552-4604"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}